Labeled for this condition
Medicines for hepatitis b
7 medicines have an FDA label indicated for hepatitis b; 4 are listed from generic labelers and 0 have a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for hepatitis b?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Entecavir | Baraclude | 15 labelers | $0.219 per tablet 0.5 mg tablet | Yes | No current entry | 5 |
| Lamivudine | Epivir | 14 labelers | $0.489 per tablet 150 mg tablet | Yes | No current entry | 2 |
| Tenofovir disoproxil | Viread | 15 labelers | $0.294 per tablet 300 mg tablet | Yes | No current entry | 0 |
| Adefovir dipivoxil | none listed | 2 labelers | $21.73 per tablet 10 mg tablet | Yes | No current entry | 0 |
| Peginterferon alfa 2a | Pegasys | none listed | n/a | Yes | Resolved | 0 |
| Human hepatitis b virus immune globulin | Nabi-Hb | none listed | n/a | No | No current entry | 0 |
| Tenofovir alafenamide | Vemlidy | none listed | $51.98 per tablet 25 mg tablet | Yes | No current entry | 0 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price